Precise Bio is a regenerative medicine company advancing the use of bio-printed tissues and organs in ophthalmology patients. The company is also building a broad portfolio of R&D programs in additional medical disciplines.
The company's commercial and R&D programs are based on its 4D bio-fabrication technology. This platform comprises cell expansion, biomaterials, processes, printing technology, and other technologies.
The company's technology platform allows it to advance its fabricated human cornea program concurrent with the development of other organs and tissues for use in ophthalmic indications. Moreover, the company's technology overcomes multiple challenges in scalable, reproducible manufacturing of bio-printed tissues and organs.
The company maintains offices, laboratories, and production facilities in North Carolina, United States, and Shoham, Israel.
Cumulative Funding Raised Over Time ($)
Employees Over Time
Precise Bio Climate Tech relevance
null
Latest News
No Data, yet.
Sorry, no content found under this section.
Mar 31, 2025
www.themarker.com
בשתי דקות בלבד: בשיבא ידפיסו קרניות להשתלה בבני אדם
#Product Stage
Jul 18, 2022
www.prnewswire.com
Carl Zeiss Meditec and Precise Bio Announce Partnership in the Development and Commercialization of Tissue-Based Implants for Ophthalmology
#Partners #Investment
Aug 4, 2020
www.globes.co.il
איברים מלאכותיים מתאים חיים: עיניים הן רק ההתחלה
#Investment, Expand
Jul 30, 2020
www.themarker.com
פרסייס ביו בנבחרת הסטארטאפים 2020 של TheMarker
#Customers #Layoffs
Apr 30, 2019
www.ncbiotech.org
Precise Bio Developing '4-D' Process for Biofabricating Tissues, Organs